Lithotripsy

Safety and effectiveness of an intravascular lithotripsy system (Shockwave Coronary IVL System, Shockwave Medical) in de novo, calcified, stenotic coronary arteries.

In patients with calcified peripheral artery lesions treated with a drug-coated balloon, those who were pretreated with intravascular lithotripsy had better procedural outcomes than those pretreated with angioplasty, a speaker said at VIVA.

Among patients with severely calcified coronary lesions, use of intravascular lithotripsy was associated with low rates of 30-day MACE and high rates of procedural success, according to the single-arm DISRUPT CAD III study.

SAN FRANCISCO — An intravascular lithotripsy device used for vessel preparation for stenting in patients with severely calcified coronary lesions was safe and effective, according to results from the DISRUPT CAD II study presented at TCT 2019.

Shockwave Medical announced that the FDA has granted a breakthrough device designation to its intravascular lithotripsy device for the treatment of complex calcified CVD.